Tevogen Bio Holdings Inc. 8-K

What Happened

• Tevogen Bio Holdings Inc. filed a Form 8-K reporting that it amended its Certificate of Incorporation to change the company name to “Tevogen Inc.” The Certificate of Amendment was filed on July 29, 2026 and the name change became effective July 30, 2026.
• The Board also approved a corresponding amendment to the company’s Amended and Restated Bylaws to reflect the new name. No other changes were made to the Bylaws.
• The filing notes that the company’s common stock and public warrants will continue to trade on the Nasdaq Global Market under the ticker symbols “TVGN” (for both), and the CUSIP numbers remain 88165K200 (common stock) and 88165K119 (public warrants).

Key Details

• Old name: Tevogen Bio Holdings Inc.; New name: Tevogen Inc.; effective date: July 30, 2026.
• Certificate of Amendment filed July 29, 2026; Bylaws amended to reflect name change effective July 30, 2026.
• Trading ticker(s) unchanged: TVGN (Nasdaq). CUSIPs unchanged: 88165K200 (common stock), 88165K119 (public warrants).
• The name change does not affect the rights of security holders.

Why It Matters

• This is primarily a corporate rebranding/legal name change; it does not alter shareholder rights, ticker symbols, or CUSIP identifiers, so investors’ holdings and trading should be unaffected.
• Shareholders and service providers (brokerage accounts, tax records, correspondence) may need to note the company’s new legal name for record-keeping and future filings.